
Imagine this: A critical medication is being manufactured, and the difference between success and failure lies in maintaining an aseptic environment where even microscopic contaminants are eliminated from the production process. In the pharmaceutical and biotech industries, every link in the value chain faces mounting pressure to deliver more: more safety, more efficiency, more compliance while tolerating less risk. This pursuit of nothing isn’t about absence – it's about achieving exceptional process control where risks are engineered out. Through our partnership with Franz Ziel, a leader in barrier technology, Körber is enhancing value for customers by integrating proven aseptic technologies into our comprehensive pharmaceutical ecosystem.
Highlights:
- What key trends are reshaping aseptic processing today?
- How do advanced barrier technologies address today’s regulatory challenges?
- What makes the combination of expert collaboration and ecosystem integration so powerful?




